Literature DB >> 2856269

Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals.

M Abecassis1, J Falk, V Dindzans, W Lopatin, L Makowka, G Levy, R Falk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2856269

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Prostaglandin E1 (PGE1) attenuates vasoconstriction induced by PGE2, PGD2 and phorbol myristate acetate in the perfused rat liver.

Authors:  H Inaba; M Araki; T Numai; T Mizuguchi
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

2.  Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report.

Authors:  S B Sinclair; G A Levy
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

3.  Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis.

Authors:  A Jacques; C Bleau; J-P Martin; L Lamontagne
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

4.  Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.

Authors:  S B Sinclair; P D Greig; L M Blendis; M Abecassis; E A Roberts; M J Phillips; R Cameron; G A Levy
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Altered pathogenicity in the liver induced by a mouse hepatitis virus type 3 thermosensitive mutant.

Authors:  J P Martin; A Bingen; F Koehren; J P Gut; A Kirn
Journal:  J Hepatol       Date:  1991-07       Impact factor: 25.083

6.  Interaction of mouse hepatitis virus 3 with Kupffer cells explanted from susceptible and resistant mouse strains. Antiviral activity, interleukin-1 synthesis.

Authors:  F Keller; C Schmitt; A Kirn
Journal:  FEMS Microbiol Immunol       Date:  1988-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.